Cargando…
A core outcome set for clinical trials on non-specific low back pain: study protocol for the development of a core domain set
BACKGROUND: Low back pain (LBP) is one of the most disabling and costly disorders affecting modern society, and approximately 90% of patients are labelled as having non-specific LBP (NSLBP). Several interventions for patients with NSLBP have been assessed in clinical trials, but heterogeneous report...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4308079/ https://www.ncbi.nlm.nih.gov/pubmed/25540987 http://dx.doi.org/10.1186/1745-6215-15-511 |
_version_ | 1782354545152622592 |
---|---|
author | Chiarotto, Alessandro Terwee, Caroline B Deyo, Richard A Boers, Maarten Lin, Chung-Wei Christine Buchbinder, Rachelle Corbin, Terry P Costa, Leonardo OP Foster, Nadine E Grotle, Margreth Koes, Bart W Kovacs, Francisco M Maher, Chris G Pearson, Adam M Peul, Wilco C Schoene, Mark L Turk, Dennis C van Tulder, Maurits W Ostelo, Raymond W |
author_facet | Chiarotto, Alessandro Terwee, Caroline B Deyo, Richard A Boers, Maarten Lin, Chung-Wei Christine Buchbinder, Rachelle Corbin, Terry P Costa, Leonardo OP Foster, Nadine E Grotle, Margreth Koes, Bart W Kovacs, Francisco M Maher, Chris G Pearson, Adam M Peul, Wilco C Schoene, Mark L Turk, Dennis C van Tulder, Maurits W Ostelo, Raymond W |
author_sort | Chiarotto, Alessandro |
collection | PubMed |
description | BACKGROUND: Low back pain (LBP) is one of the most disabling and costly disorders affecting modern society, and approximately 90% of patients are labelled as having non-specific LBP (NSLBP). Several interventions for patients with NSLBP have been assessed in clinical trials, but heterogeneous reporting of outcomes in these trials has hindered comparison of results and performance of meta-analyses. Moreover, there is a risk of selective outcome reporting bias. To address these issues, the development of a core outcome set (COS) that should be measured in all clinical trials for a specific health condition has been recommended. A standardized set of outcomes for LBP was proposed in 1998, however, with evolution in COS development methodology, new instruments, interventions, and understanding of measurement properties, it is appropriate to update that proposal. This protocol describes the methods used in the initial step in developing a COS for NSLBP, namely, establishing a core domain set that should be measured in all clinical trials. METHODS/DESIGN: An International Steering Committee including researchers, clinicians, and patient representatives from four continents was formed to guide the development of this COS. The approach of initiatives like Core Outcome Measures in Effectiveness Trials (COMET) and Outcome Measures in Rheumatology (OMERACT) was followed. Participants were invited to participate in a Delphi study aimed at generating a consensus-based core domain set for NSLBP. A list of potential core domains was drafted and presented to the Delphi participants who were asked to judge which domains were core. Participant suggestions about overlap, aggregation, or addition of potential core domains were addressed during the study. The patients’ responses were isolated to assess whether there was substantial disagreement with the rest of the Delphi panel. A priori thresholds for consensus were established before each Delphi round. All participants’ responses were analysed from a quantitative and qualitative perspective to ascertain that no substantial discrepancies between the two approaches emerged. DISCUSSION: We present the initial step in developing a COS for NSLBP. The next step will be to determine which measurement instruments adequately cover the domains. |
format | Online Article Text |
id | pubmed-4308079 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-43080792015-01-28 A core outcome set for clinical trials on non-specific low back pain: study protocol for the development of a core domain set Chiarotto, Alessandro Terwee, Caroline B Deyo, Richard A Boers, Maarten Lin, Chung-Wei Christine Buchbinder, Rachelle Corbin, Terry P Costa, Leonardo OP Foster, Nadine E Grotle, Margreth Koes, Bart W Kovacs, Francisco M Maher, Chris G Pearson, Adam M Peul, Wilco C Schoene, Mark L Turk, Dennis C van Tulder, Maurits W Ostelo, Raymond W Trials Study Protocol BACKGROUND: Low back pain (LBP) is one of the most disabling and costly disorders affecting modern society, and approximately 90% of patients are labelled as having non-specific LBP (NSLBP). Several interventions for patients with NSLBP have been assessed in clinical trials, but heterogeneous reporting of outcomes in these trials has hindered comparison of results and performance of meta-analyses. Moreover, there is a risk of selective outcome reporting bias. To address these issues, the development of a core outcome set (COS) that should be measured in all clinical trials for a specific health condition has been recommended. A standardized set of outcomes for LBP was proposed in 1998, however, with evolution in COS development methodology, new instruments, interventions, and understanding of measurement properties, it is appropriate to update that proposal. This protocol describes the methods used in the initial step in developing a COS for NSLBP, namely, establishing a core domain set that should be measured in all clinical trials. METHODS/DESIGN: An International Steering Committee including researchers, clinicians, and patient representatives from four continents was formed to guide the development of this COS. The approach of initiatives like Core Outcome Measures in Effectiveness Trials (COMET) and Outcome Measures in Rheumatology (OMERACT) was followed. Participants were invited to participate in a Delphi study aimed at generating a consensus-based core domain set for NSLBP. A list of potential core domains was drafted and presented to the Delphi participants who were asked to judge which domains were core. Participant suggestions about overlap, aggregation, or addition of potential core domains were addressed during the study. The patients’ responses were isolated to assess whether there was substantial disagreement with the rest of the Delphi panel. A priori thresholds for consensus were established before each Delphi round. All participants’ responses were analysed from a quantitative and qualitative perspective to ascertain that no substantial discrepancies between the two approaches emerged. DISCUSSION: We present the initial step in developing a COS for NSLBP. The next step will be to determine which measurement instruments adequately cover the domains. BioMed Central 2014-12-26 /pmc/articles/PMC4308079/ /pubmed/25540987 http://dx.doi.org/10.1186/1745-6215-15-511 Text en © Chiarotto et al.; licensee BioMed Central. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Study Protocol Chiarotto, Alessandro Terwee, Caroline B Deyo, Richard A Boers, Maarten Lin, Chung-Wei Christine Buchbinder, Rachelle Corbin, Terry P Costa, Leonardo OP Foster, Nadine E Grotle, Margreth Koes, Bart W Kovacs, Francisco M Maher, Chris G Pearson, Adam M Peul, Wilco C Schoene, Mark L Turk, Dennis C van Tulder, Maurits W Ostelo, Raymond W A core outcome set for clinical trials on non-specific low back pain: study protocol for the development of a core domain set |
title | A core outcome set for clinical trials on non-specific low back pain: study protocol for the development of a core domain set |
title_full | A core outcome set for clinical trials on non-specific low back pain: study protocol for the development of a core domain set |
title_fullStr | A core outcome set for clinical trials on non-specific low back pain: study protocol for the development of a core domain set |
title_full_unstemmed | A core outcome set for clinical trials on non-specific low back pain: study protocol for the development of a core domain set |
title_short | A core outcome set for clinical trials on non-specific low back pain: study protocol for the development of a core domain set |
title_sort | core outcome set for clinical trials on non-specific low back pain: study protocol for the development of a core domain set |
topic | Study Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4308079/ https://www.ncbi.nlm.nih.gov/pubmed/25540987 http://dx.doi.org/10.1186/1745-6215-15-511 |
work_keys_str_mv | AT chiarottoalessandro acoreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset AT terweecarolineb acoreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset AT deyoricharda acoreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset AT boersmaarten acoreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset AT linchungweichristine acoreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset AT buchbinderrachelle acoreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset AT corbinterryp acoreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset AT costaleonardoop acoreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset AT fosternadinee acoreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset AT grotlemargreth acoreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset AT koesbartw acoreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset AT kovacsfranciscom acoreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset AT maherchrisg acoreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset AT pearsonadamm acoreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset AT peulwilcoc acoreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset AT schoenemarkl acoreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset AT turkdennisc acoreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset AT vantuldermauritsw acoreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset AT osteloraymondw acoreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset AT chiarottoalessandro coreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset AT terweecarolineb coreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset AT deyoricharda coreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset AT boersmaarten coreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset AT linchungweichristine coreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset AT buchbinderrachelle coreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset AT corbinterryp coreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset AT costaleonardoop coreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset AT fosternadinee coreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset AT grotlemargreth coreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset AT koesbartw coreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset AT kovacsfranciscom coreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset AT maherchrisg coreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset AT pearsonadamm coreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset AT peulwilcoc coreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset AT schoenemarkl coreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset AT turkdennisc coreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset AT vantuldermauritsw coreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset AT osteloraymondw coreoutcomesetforclinicaltrialsonnonspecificlowbackpainstudyprotocolforthedevelopmentofacoredomainset |